Review Article
Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review
Submitted: 30 January 2018 | Published: 06 December 2018
About the author(s)
Yahaya Mohammed, Department of Medical Microbiology and Parasitology, Faculty of Basic Clinical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, NigeriaAaron O. Aboderin, Department of Medical Microbiology and Parasitology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
Iruka N. Okeke, Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
Adebola T. Olayinka, Department of Medical Microbiology and Parasitology, Faculty of Medicine, Ahmadu Bello University, Zaria, Nigeria
Abstract
Background: The World Health Assembly adopted the Global Action Plan on Antimicrobial Resistance, which includes improving the knowledge base through surveillance and research. Noteworthily, the World Health Organization has advocated a Global Antimicrobial Resistance Surveillance System to address the plan’s surveillance objective, with most African countries enrolling in or after 2017.
Aim: The aim of this article was to review prior data on antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa with a view for future control and intervention strategies.
Methods: We used the Preferred Reporting Items for Systematic Review and Meta-Analysis (or ‘PRISMA’) guidelines to search the PubMed and African Journals Online databases, as well as additional articles provided by the Nigeria Centre for Disease Control, for articles reporting on the antibiotic susceptibility of V. cholerae between January 2000 and December 2017.
Results: We identified 340 publications, of which only 25 (reporting from 16 countries within the sub-Saharan African region) were eligible. The majority (20; 80.0%) of the cholera toxigenic V. cholerae isolates were of the serogroup O1 of the El Tor biotype with Ogawa and Inaba serotypes predominating. Resistance was predominantly documented to trimethoprim-sulphamethoxazole (50% of the studies), ampicillin (43.3% of the studies), chloramphenicol (43.3% of the studies) and streptomycin (30% of the studies). Resistance mechanisms were reported in 40% of the studies.
Conclusion: Our results demonstrate a documented antimicrobial resistance of V. cholerae to multiple antibiotic classes, including cell wall active agents and antimetabolites with evidence of phenotypic/genotypic resistance to fluoroquinolones.
Keywords
Metrics
Total abstract views: 4643Total article views: 4968
Crossref Citations
1. Retrospective Analysis of the Serovars and Antibiogram of Vibrio cholerae Isolates of the 2017 Ilorin Cholera Outbreak, Nigeria
Dele Ohinoyi Amadu, Idris Nasir Abdullahi, Ezekiel Seibu, Abayomi Fadeyi, Khadeejah Kamaldeen, Aliu Ajibola Akanbi, Chukwudi Crescent Okwume, Motunrayo Bukola Amadu, Charles Nwabuisi
Infection & Chemotherapy vol: 53 issue: 2 first page: 368 year: 2021
doi: 10.3947/ic.2021.0001